• Founded a dual-focus venture in healthcare consultancy and AI-driven platform development (bootstrapped). • Providing strategic advisory, product design, AI use case discovery and AI adoption support for one healthcare client. • Developing a healthcare platform (stealth-mode) aimed at transforming a multi-million-dollar healthcare domain.

Led two Innovation-as-a-Service programs, one healthcare ecosystem assessment, and developed connected care strategies across two distinct geographies. Directed the planning and execution of technology-enabled care models, including a smart healthcare infrastructure project and personalized care initiatives. Provided strategic consulting across opportunity mapping, portfolio planning, and go-to-market strategy development for two healthcare markets.

Developed and launched digital health platforms such as care management portals with curated formularies featuring 15-20 healthcare products and services, and integrated AI-adoption workflows to support operational automation. Orchestrated product and portfolio strategies for multi-national healthcare deployments, including two major U.S. markets. Developed integrated healthcare delivery models, including "compose-your-care" frameworks, consumer membership programs, senior care pathways, and hub-and-spoke logistics infrastructure. Oversaw the design and development of rapid-deployable healthcare infrastructure, culminating in a design patent. Formulated hybrid innovation strategies, resulting in eight plus external strategic partnerships with technology vendors, health systems, and institutional care providers. Conducted strategic assessments for one Ontario Healt

Founded a part-time healthcare venture with one mission: to improve medication adherence and compliance through patient-centric, technology-driven solutions. Delivered expert advisory services to one healthcare client, focusing on medication adherence ecosystem assessments, process automation, and the integration of emerging technologies.

Designed and executed product portfolio, and business strategies for innovative healthcare offerings across four categories: prescription medicines, consumer health, diagnostics, and advanced metabolic therapeutics. Led end-to-end product development of metabolic solutions across six therapeutic areas, including cardiometabolic care, oncology, neuroscience, pain management, critical care, and women's health.

Directed global regulatory and technical operations across four key markets: the U.S., Canada, India, and the MENA region. Managed regulatory affairs projects for prescription products in diabetes and allergic rhinitis, as well as a range of consumer healthcare products. Acted as the pharmaceutical and regulatory lead for R&D initiatives, including a Metformin R-(+)-lipoate formulation (resulting in one regulatory submission), combination therapies, and salts of approved Rx drugs with physiological metabolites. Built a distributed team of 30+ regulatory and design professionals across the U.S., Canada, Europe, MENA, and India.